Table 1.
Anthropometric and clinical parameters of patient population
| Study | Endurance polarized | Endurance standard |
|---|---|---|
| TOTAL (n) | 12 | 9 |
| Age (years), mean (SD) | 60.67 (8.70) | 59.11 (9.87) |
| BMI (kg/m2), mean (SD) | 26.14 (3.53) | 28.53 (4.01) |
| VO2peak (ml/min/kg), mean (SD) | 23.03 (3.68) | 21.6 (4.71) |
| Breast cancer, n (%) | 7 (58.33) | 4 (44.44) |
| Prostate cancer, n (%) | 5 (41.66) | 5 (55.55) |
| Stage, n (%) | ||
| I | 9 (75) | 7 (77.77) |
| II | 3 (25) | 2 (22.22) |
| III | 0 (0) | 0 (0) |
| IV | 0 (0) | 0 (0) |
| Treatment, n (%) | ||
| Adjuvant hormone therapy | 7 (58.33) | 5 (55.55) |
| Antibody therapy | 1 (8.3) | 1 (11.11) |
| Neo-adjuvant chemotherapy | 0 (0) | 2 (22.22) |
| Intraoperative radiation therapy | 1 (8.3) | 0 (0) |
| Radiation therapy | 9 (75) | 6 (66.66) |
| Operative procedures, n (%) | 10 (83.33) | 8 (88.88) |
n number of participants, SD standard deviation, BMI body mass index, VO2peak peak oxygen uptake